Bubs Australia (BUB) Status update summary

Strategic direction and leadership

• Introduced a highly experienced executive team focused on disciplined execution, global expansion, and value creation.

• Emphasized robust governance, a strategic reset, and a unified operating cadence, resulting in doubled revenue and inaugural profits.

• Board rigorously tested assumptions and execution risks, ensuring disciplined capital allocation and strong governance.

• Outlined a five-year growth strategy targeting core business strengthening, new market expansion, and innovation.

• Performance culture and strategic partnerships enable innovation and growth.

Market positioning and growth strategy

• Focused on premium infant nutrition, leveraging strong brand trust, clean label, and quality to command higher prices.

• Leading in goat formula, with expansion into toddler, adult nutrition (CapriLac), and adjacent categories.

• Proven ability to scale in Australia, China, and the U.S., with rapid U.S. growth from zero to $60 million in four years.

• Targeting digitally savvy, urban, higher-income consumers for high repeat and advocacy rates.

• Marketing flywheel lowers acquisition costs and increases awareness through digital and retail channels.

Financial performance and guidance

• FY26 revenue guidance upgraded to AUD 120–125 million ($120–125M), reflecting 22–27% growth over prior year.

• Underlying FY26 EBITDA guidance is AUD 9–11 million, with 1H FY26 EBITDA at $4.4M.

• Achieved 26% revenue CAGR from FY23–FY26, with strong operating leverage and low debt.

• Capital-light approach and disciplined investment drive positive cash flow and margin growth.

• Large inventory build to support growth, with OCF expected to turn positive by FY27.